A 12-week, randomized, open-label, parallel-group trial of topiramate in limiting weight gain during olanzapine treatment in patients with schizophrenia.

Authors
Category Primary study
JournalSchizophrenia research
Year 2006
This article has no abstract
Epistemonikos ID: da4903f2e805289f720e901ae3bdcea7fe249447
First added on: Jan 31, 2012